Quest Diagnostics beat Q1 estimates with 15.2% revenue growth and lifted its 2025 guidance amid rising volumes and solid ...

Philip Morris International Inc. reported strong Q2 results, with smoke-free products driving growth. Click for why PM shares fell and future growth expectations.

Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...